DrugPatentWatch Database Preview
Drugs in Development Information for Ataciguat
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Ataciguat?
Ataciguat is an investigational drug.
There have been 4 clinical trials for Ataciguat.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2015.
The most common disease conditions in clinical trials are Constriction, Pathologic, Aortic Valve Stenosis, and Neuralgia. The leading clinical trial sponsors are Sanofi, Sanofi-Synthelabo, and National Center for Research Resources (NCRR).
Summary for Ataciguat
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 68 |
| WIPO Patent Applications | 42 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2015-06-01) |
| Vendors | 22 |
Recent Clinical Trials for Ataciguat
| Title | Sponsor | Phase |
|---|---|---|
| A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification | National Institutes of Health (NIH) | Phase 2 |
| A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification | Sanofi | Phase 2 |
| A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification | Mayo Clinic | Phase 2 |
Clinical Trial Summary for Ataciguat
Top disease conditions for Ataciguat
Top clinical trial sponsors for Ataciguat
US Patents for Ataciguat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
